Multiple hepatic receptors cooperate to eliminate secretory mucins aberrantly entering the bloodstream: Are circulating cancer mucins the "tip of the iceberg"?

Cancer Research

Volumn 66, Issue 4, 2006, Pages 2433-2441

  Wahrenbrock, Mark G ^a   Varki, Ajit ^a  

^a University of California San Diego   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; GLYCAN RECOGNIZING HEPATIC CLEARANCE RECEPTOR; MUCIN; PLASMA PROTEIN; RECEPTOR; TRITIUM; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOMA; COLUMNAR EPITHELIUM; CONTROLLED STUDY; EPITHELIUM CELL; HALF LIFE TIME; HUMAN; HUMAN CELL; INFLAMMATION; LIVER CELL; LIVER CLEARANCE; LIVER DISEASE; MICROTHROMBUS; NONHUMAN; ORGAN INJURY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN GLYCOSYLATION; PROTEIN SECRETION; RECEPTOR INTRINSIC ACTIVITY; RETICULOENDOTHELIAL SYSTEM;

ADENOCARCINOMA; ANIMALS; ANTIGENS, CD44; CELL LINE, TUMOR; COLONIC NEOPLASMS; HUMANS; LIVER; MANNOSE-BINDING LECTINS; MICE; MICE, INBRED C57BL; MUCINS; POLYSACCHARIDES; RECEPTORS, CELL SURFACE; RECEPTORS, SCAVENGER; RETICULOENDOTHELIAL SYSTEM; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 33644506102     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-05-3851     Document Type: Article

References (77)

1. Thornton D, Sheehan JK. From mucins to mucus: toward a more coherent understanding of this essential barrier. Proc Am Thorac Soc 2004;1:54-61.
2. Packer L, Williams S, Callaghan S, Gotley D, Mcguckin M. Expression of the cell surface mucin gene family in adenocarcinomas. Int J Oncol 2004;25:1119-26.
3. Moniaux N, Escande F, Porchet N, Aubert J, Batra S. Structural organization and classification of the human mucin genes. Front Biosci 2001;6:D1192-206.
4. Byrd J, Bresalier R. Mucins and mucin binding proteins in colorectal cancer. Cancer Metastasis Rev 2004;23:77-99.
5. Hollingsworth M, Swanson BJ. Mucins in cancer: protection and control of the cell surface. Nat Rev Cancer 2004;4:45-60.
6. Thornton D, Khan N, Mehrotra R, et al. Salivary mucin MG1 is comprised almost entirely of different glycosylated forms of the MUC5B gene product. Glycobiology 1999;9:293-302.
7. Robbe C, Capon C, Coddeville B, Michalski J. Structural diversity and specific distribution of O-glycans in normal human mucins along the intestinal tract. Biochem J 2004;384:307-16.
8. Campbell S, Larsen J, Seif M, et al. Mosaic characteristics of human endometrial epithelium in vitro: analysis of secretory markers and cell surface ultrastructure. Mol Hum Reprod 2000;6:41-9.
9. Jass J, Walsh MD. Altered mucin expression in the gastrointestinal tract: a review. J Cell Mol Med 2001;5:327-51.
10. Van Klinken BJ, Dekker J, Buller H, De Bolos C, Einerhand A. Biosynthesis of mucins (MUC2-6) along the longitudinal axis of the human gastrointestinal tract. Am J Physiol 1997;273:G296-302.
11. Taylor-Papadimitriou J, Finn O. Biology, biochemistry and immunology of carcinoma-associated mucins. Immunol Today 1997;18:105-7.
12. Lapointe J, Li C, Higgins J, et al. Gene expression profiling identifies clinically relevant subtypes of prostate cancer. Proc Natl Acad Sci U S A 2004;101:811-6.
13. Olson F, Johansson M, Klinga-Levan K, et al. Blood group A glycosyltransferase occurring as alleles with high sequence difference is transiently induced during a Nippostrongylus brasiliensis parasite infection. J Biol Chem 2002;277:15044-52.
14. Vinall L, King M, Novelli M, et al. Altered expression and allelic association of the hypervariable membrane mucin MUC1 in Helicobacter pylori gastritis. Gastroenterology 2002;123:41-9.
15. Brockhausen I. Glycodynamics of mucin biosynthesis in gastrointestinal tumor cells. Adv Exp Med Biol 2003;535:163-88.
16. Berg E, Mcevoy LM, Berlin C, Bargatze R, Butcher E. L-selectin-mediated lymphocyte rolling on MAdCAM-1. Nature 1993;366:695-8.
17. Baumhueter S, Singer MS, Henzel W, et al. Binding of L-selectin to the vascular sialomucin CD34. Science 1993;262:436-8.
18. Satomaa T, Renkonen O, Helin J, Kirveskari J, Mäkitie A, Renkonen R. O-glycans on human high endothelial CD34 putatively participating in L-selectin recognition. Blood 2002;99:2609-11.
19. Norgard K, Moore K, Diaz S, et al. Characterization of a specific ligand for P-selectin on myeloid cells. A minor glycoprotein with sialylated O-linked oligosaccharides. J Biol Chem 1993;268:12764-74.
20. Fogel M, Friederichs J, Zeller Y, et al. CD24 is a marker for human breast carcinoma. Cancer Lett 1999;143:87-94.
21. Kristiansen G, Sammar M, Altevogt P. Tumour biological aspects of CD24, a mucin-like adhesion molecule. J Mol Histol 2004;35:255-62.
22. Drew E, Merzaban J, Seo W, Ziltener H, Mcnagny K. CD34 and CD43 inhibit mast cell adhesion and are required for optimal mast cell reconstitution. Immunity 2005;22:43-57.
23. Mcever R. Selectins: lectins that initiate cell adhesion under flow. Curr Opin Cell Biol 2002;14:581-6.
24. Hakomori S. Tumor malignancy denned by aberrant glycosylation and sphingo(glyco)lipid metabolism. Cancer Res 1996;56:5309-18.
25. Duffy M. CA 19-9 as a marker for gastrointestinal cancers: a review. Ann Clin Biochem 1998;35:364-70.
26. Yin B, Dnistrian A, Lloyd K. Ovarian cancer antigen CA125 is encoded by the MUC16 mucin gene. Int J Cancer 2002;98:737-40.
27. Satake K, Kanazawa G, Kho I, Chung Y, Umeyama K. Evaluation of serum pancreatic enzymes, carbohydrate antigen 19-9, and carcinoembryonic antigen in various pancreatic diseases. Am J Gastroenterol 1985;80:630-6.
28. Haglund C, Roberts P, Kuusela P, Scheinin T, Makela O, Jalanko H. Evaluation of CA 19-9 as a serum tumour marker in pancreatic cancer. Br J Cancer 1986;53:197-202.
29. Ramage JK, Donaghy A, Farrant J, Iorns R, Williams R. Serum tumor markers for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis. Gastroenterology 1995;108:865-9.
30. Albert M, Steinberg W, Henry J. Elevated serum levels of tumor marker CA19-9 in acute cholangitis. Dig Dis Sci 1988;33:1223-5.
31. Duffy MJ, O'Sullivan F, McDonnell TJ, Fitzgerald MX. Increased concentrations of the antigen CA-19-9 in serum of cystic fibrosis patients. [letter]. Clin Chem 1985;31:1245-6.
32. Narita M, Tanaka H, Abe S, Yamada S, Kubota M, Togashi T. Close association between pulmonary disease manifestation in Mycoplasma pneumoniae infection and enhanced local production of interleukin-18 in the lung, independent of y interferon. Clin Diagn Lab Immunol 2000;7:909-14.
33. Harada T, Kubota T, Aso T. Usefulness of CA19-9 versus CA125 for the diagnosis of endometriosis. Fertil Steril 2002;78:733-9.
34. Micha J, Goldstein B, Robinson P, Rettenmaier M, Brown JV. Abdominal/pelvic coccidioidomycosis. Gynecol Oncol 2005;96:256-8.
35. Moore E, Soper D. Clinical utility of CA125 levels in predicting laparoscopically confirmed salpingitis in patients with clinically diagnosed pelvic inflammatory disease. Infect Dis Obstet Gynecol 1998;6:182-5.
36. Muyldermans M, Cornillie F, Koninckx P. CA125 and endometriosis. Hum Reprod Update 1995;1:173-87.
37. Wahrenbrock M, Borsig L, Le D, Varki N, Varki A. Selectin-mucin interactions as a probable molecular explanation for the association of Trousseau syndrome with mucinous adenocarcinomas. J Clin Invest 2003;112:853-62.
38. Tozawa R, Ishibashi S, Osuga J, et al. Asialoglycoprotein receptor deficiency in mice lacking the major receptor subunit-Its obligate requirement for the stable expression of oligomeric receptor. J Biol Chem 2001;276:12624-8.
39. Onami T, Lin M, Page D, et al. Generation of mice deficient for macrophage galactose- and N-acetylgalactosamine-specific lectin: limited role in lymphoid and erythroid homeostasis and evidence for multiple lectins. Mol Cell Biol 2002;22:5173-81.
40. Tangvoranuntakul P, Gagneux P, Diaz S, et al. Human uptake and incorporation of an immunogenic nonhuman dietary sialic acid. Proc Natl Acad Sci U S A 2003;100:12045-50.
41. Gupta R, Jentoft N. Subunit structure of porcine submaxillary mucin. Biochemistry 1989;28:6114-21.
42. Belley JG. Glycoprotein and proteoglycan techniques. New York: Elsevier; 1985.
43. Van Lenten L, Ashwell G. Studies on the chemical and enzymatic modification of glycoproteins A general method for the tritiation of sialic acid-containing glycoproteins. J Biol Chem 1971;246:1889-94.
44. Gahmberg C. Tritium labeling of cell-surface glycoproteins and glycolipids using galactose oxidase. Methods Enzymol 1978;50:204-6.
45. Ellies L, Ditto D, Levy G, et al. Sialyltransferase ST3Gal-IV operates as a dominant modifier of hemostasis by concealing asialoglycoprotein receptor ligands. Proc Natl Acad Sci U S A 2002;99:10042-7.
46. Yang M, Leake D, Rice-Evans CA. Non-oxidative modification of native low-density lipoprotein by oxidized low-density lipoprotein. Biochem J 1996;316:377-80.
47. Schneider W, Basu S, Mcphaul MJ, Goldstein J, Brown M. Solubilization of the low density lipoprotein receptor. Proc Natl Acad Sci U S A 1979;76:5577-81.
48. Greenway C, Innes IR, Pushka K, Scott G, Sitar DS. Changes in hepatic blood volume on galactose and indocyanine green uptake by cat liver. Am J Physiol 1989;256:G524-31.
49. 1H NMR spectroscopy. J Biol Chem 1988;263:18253-68.
50. Weigel PH, Yik J. Glycans as endocytosis signals: the cases of the asialoglycoprotein and hyaluronan/chondroitin sulfate receptors. Biochim Biophys Acta Gen Subj 2002;1572:341-63.
51. Park E, Baenziger J. Closely related mammals have distinct asialoglycoprotein receptor carbohydrate specificities. J Biol Chem 2004;279:40954-9.
52. 4-receptor: relating specificity to function. Methods Enzymol 2003;363:121-33.
53. Hiltbold E, Vlad A, Ciborowski P, Watkins SC, Finn O. The mechanism of unresponsiveness to circulating tumor antigen MUC1 is a block in intracellular sorting and processing by dendritic cells. J Immunol 2000;165:3730-41.
54. Narita M, Bu G, Herz J, Schwartz A. Two receptor systems are involved in the plasma clearance of tissue-type plasminogen activator (t-PA) in vivo. J Clin Invest 1995;96:1164-8.
55. 4-4GalNAc β 1,4GlcNAc β 1,2Man α that mediates rapid clearance of lutropin. Cell 1991;67:1103-10.
56. Leteux C, Chai W, Loveless R, et al. The cysteine-rich domain of the macrophage mannose receptor is a multispecific lectin that recognizes chondroitin sulfates A and B and sulfated oligosaccharides of blood group Lewis(a) and Lewis(x) types in addition to the sulfated N-glycans of lutropin. J Exp Med 2000;191:1117-26.
57. Inaba T, Sano H, Kawahito Y, et al. Induction of cyclooxygenase-2 in monocyte/macrophage by mucins secreted from colon cancer cells. Proc Natl Acad Sci U S A 2003;100:2736-41.
58. Acton S, Rigotti A, Landschulz K, Xu S, Hobbs H, Krieger M. Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science 1996;271:518-20.
59. Krieger M, Herz J. Structures and functions of multiligand lipoprotein receptors: macrophage scavenger receptors and LDL receptor-related protein (LRP). Annu Rev Biochem 1994;63:601-37.
60. Platt N, Gordon S. Is the class A macrophage scavenger receptor (SR-A) multifunctional? The mouse's tale. J Clin Invest 2001;108:649-54.
61. Inoue M, Fujii H, Kaseyama H, Yamashina I, Nakada H. Stimulation of macrophages by mucins through a macrophage scavenger receptor. Biochem Biophys Res Commun 1999;264:276-80.
62. Harris EN, Weigel JA, Weigel PH. Endocytic Function, Glycosaminoglycan specificity, and antibody sensitivity of the recombinant human 190-kDa hyaluronan receptor for endocytosis (HARE). J Biol Chem 2004;279:36201-9.
63. Mahteme H, Graf W, Larsson B, Gustafson S. Uptake of hyaluronan in hepatic metastases after blocking of liver endothetial cell receptors. Glycoconj J 1998;15:935-9.
64. Kodama T, Freeman M, Rohrer L, Zabrecky J, Matsudaira P, Krieger M. Type I macrophage scavenger receptor contains α-helical and collagen-like coiled coils. Nature 1990;343:531-5.
65. Van Oosten M, Van De Bilt E, Van Berkel TJ, Kuiper J. New scavenger receptor-like receptors for the binding of lipopolysaccharide to liver endothelial and Kupffer cells. Infect Immun 1998;66:5107-12.
66. Yednock TA, Butcher EC, Stoolman L, Rosen S. Receptors involved in lymphocyte homing: relationship between a carbohydrate-binding receptor and the MEL-14 antigen. J Cell Biol 1987;104:725-31.
67. Imai Y, True D, Singer M, Rosen S. Direct demonstration of the lectin activity of gp90MEL, a lymphocyte homing receptor. J Cell Biol 1990;111:1225-32.
68. Singhal A, Orntoft T, Nudelman E, et al. Profiles of Lewis X-containing glycoproteins and glycolipids in sera of patients with adenocarcinoma. Cancer Res 1990;50:1375-80.
69. Harmenberg U, Wahren B, Wiechel K. Tumor markers carbohydrate antigens CA 19-9 and CA-50 and carcinoembryonic antigen in pancreatic cancer and benign diseases of the pancreatobiliary tract. Cancer Res 1988;48:1985-8.
70. Magnani JL, Brockhaus M, Smith D, Ginsburg V. Detection of glycolipid ligands by direct binding of carbohydrate-binding proteins to thin-layer chromatograms. Methods Enzymol 1982;83:235-41.
71. Varki NM, Varki A. Heparin inhibition of selectin-mediated interactions during the hematogenous phase of carcinoma metastasis: rationale for clinical studies in humans. Semin Thromb Hemost 2002;28:53-66.
72. Kim Y, Borsig L, Han H, Varki N, Varki A. Distinct selectin ligands on colon carcinoma mucins can mediate pathological interactions among platelets, leukocytes, and endothelium. Am J Pathol 1999;155:461-72.
73. Borsig L, Wong R, Feramisco J, Nadeau D, Varki NM, Varki A. Heparin and cancer revisited: mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis. Proc Natl Acad Sci U S A 2001;98:3352-7.
74. Borsig L, Wong R, Hynes R, Varki N, Varki A. Synergistic effects of L- and P-selectin in facilitating tumor metastasis can involve non-mucin ligands and implicate leukocytes as enhancers of metastasis. Proc Natl Acad Sci U S A 2002;99:2193-8.
75. Bidart J, Thuillier F, Augereau C, et al. Kinetics of serum tumor marker concentrations and usefulness in clinical monitoring. Clin Chem 1999;45:1695-707.
76. Dibaise JK, Donovan JP. Markedly elevated CA125 in hepatic cirrhosis: two case illustrations and review of the literature. J Clin Gastroenterol 1999;28:159-61.
77. Mammen E. Coagulopathies of liver disease. Clin Lab Med 1994;14:769-80.